Key result
Intravenous contrast during transthoracic echocardiography improved the visualization of endocardial border length by up to 65% and epicardial border length by up to 61%.
Why the study?
Does intravenous perflutren contrast improve the visualization of epicardial and endocardial border lengths during transthoracic echocardiography in patients evaluated for coronary artery disease?
Observational (n=73)
Blinded review
No
Does intravenous perflutren contrast improve the visualization of epicardial and endocardial border lengths during transthoracic echocardiography in patients evaluated for coronary artery disease?
Answers are grounded in this paper and cite their sources.
The use of perflutren contrast during transthoracic echocardiography significantly improves the visualization of both endocardial and epicardial borders, potentially aiding in the assessment of regional left ventricular wall thickening and myocardial ischemia.
OBJECTIVE: Precise estimation of wall motion abnormalities during routine echocardiography rests on optimal endocardial border visualization. Endocardial "dropout" may result in the misinterpretation of regional wall motion. Left ventricular opacification (LVO) with intravenous contrast improves the visualization of the left ventricular endocardial border length (EnBL). The purpose of this study was to determine if contrast also improves the visualization of the epicardial border length (EpBL) in addition to the EnBL. METHOD: This is a single center retrospective observational study. From 200 consecutive patients referred to the Echocardiography Laboratory for the assessment and evaluation of coronary artery disease, 73 patients who received contrast were enrolled. All the images were standardized using offline software. The visualized segments of the epicardium and endocardium were measured in diastole and systole, without and with contrast-enhancement and these segments were summed to provide the total visualized EnBL and EpBL. RESULTS: Contrast enhanced imaging improved EnBL by 65% and 45% in end-diastolic and end-systolic views, respectively. Similarly, EpBL was improved by 61% and 57% in end-diastolic and end-systolic views, respectively (all P values <0.05). CONCLUSION: Contrast LVO improves the EnBL as previously reported. Additionally, based upon the blinded review of 1,752 regional myocardial wall segments, this study is the first to suggest that contrast also enhances the visualization of the EpBL. This finding has direct clinical implications as the improvement in both EnBL and EpBL with contrast may assist in evaluation of regional left ventricular wall thickening which is a critical parameter used to assess for myocardial ischemia.
No takes yet. Share an insight, caveat, or question.
Sorrell et al. (2011) conducted an observational in Coronary artery disease (n=73). Intravenous contrast vs. Without contrast-enhancement was evaluated on Visualization of endocardial and epicardial border lengths (EnBL and EpBL) (65% and 45% improvement in EnBL; 61% and 57% improvement in EpBL, p=<0.05). Intravenous contrast during transthoracic echocardiography improved the visualization of endocardial border length by up to 65% and epicardial border length by up to 61%.
Synapse has enriched 10 related papers. Consider them for comparative context: